IMRX vs. ESLT

Last updated Jun 13, 2026

IMRX (Immuneering Corporation) and ESLT (Elbit Systems Ltd) are both stocks. IMRX operates in Biotechnology (Healthcare), while ESLT operates in Aerospace & Defense (Industrials). Over the past 3 years, IMRX returned -24.01%/yr vs 60.86%/yr for ESLT. At a 0.09 correlation, their price movements are largely independent.

Performance

IMRX vs. ESLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immuneering Corporation (IMRX) and Elbit Systems Ltd (ESLT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IMRX achieves a -36.32% return, which is significantly lower than ESLT's 48.00% return.

IMRX

• 1D: 1.70%
• 1M: -22.12%
• YTD: -36.32%
• 6M: -31.09%
• 1Y: 113.78%
• 3Y*: -24.01%
• 5Y*: —
• 10Y*: —

ESLT

• 1D: -6.48%
• 1M: 9.58%
• YTD: 48.00%
• 6M: 66.16%
• 1Y: 98.98%
• 3Y*: 60.86%
• 5Y*: 46.38%
• 10Y*: 26.53%

*Multi-year figures are annualized to reflect compound growth (CAGR)

IMRX vs. ESLT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
IMRX Immuneering Corporation	-36.32%	199.09%	-70.07%	51.55%	-70.01%	-17.08%
ESLT Elbit Systems Ltd	48.00%	125.14%	22.17%	31.30%	-4.82%	30.39%

Correlation

The correlation between IMRX and ESLT is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.05
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021	0.09

Fundamentals

Market Cap IMRX : $270.92M ESLT : $41.10B
EPS IMRX : -$293.00 ESLT : $12.36
PB Ratio IMRX : 0.00 ESLT : 9.65
Total Revenue (TTM) IMRX : $0.00 ESLT : $8.23B
Gross Profit (TTM) IMRX : -$698.89K ESLT : $2.03B
EBITDA (TTM) IMRX : -$15.38B ESLT : $861.06M

Return for Risk

IMRX vs. ESLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMRX

IMRX Risk / Return Rank: 75
IMRX Sharpe Ratio Rank: 72
IMRX Sortino Ratio Rank: 78
IMRX Omega Ratio Rank: 81
IMRX Calmar Ratio Rank: 76
IMRX Martin Ratio Rank: 70

ESLT

ESLT Risk / Return Rank: 90
ESLT Sharpe Ratio Rank: 92
ESLT Sortino Ratio Rank: 91
ESLT Omega Ratio Rank: 88
ESLT Calmar Ratio Rank: 88
ESLT Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMRX vs. ESLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immuneering Corporation (IMRX) and Elbit Systems Ltd (ESLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IMRX	ESLT	Difference
Sharpe ratio: Return per unit of total volatility	0.92	2.26	-1.33
Sortino ratio: Return per unit of downside risk	2.05	3.19	-1.15
Omega ratio: Gain probability vs. loss probability	1.29	1.38	-0.09
Calmar ratio: Return relative to maximum drawdown	1.98	3.83	-1.85
Martin ratio: Return relative to average drawdown	3.30	10.61	-7.31

IMRX vs. ESLT - Sharpe Ratio Comparison

The current IMRX Sharpe Ratio is 0.92, which is lower than the ESLT Sharpe Ratio of 2.26. The chart below compares the historical Sharpe Ratios of IMRX and ESLT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

IMRX vs. ESLT - Drawdown Comparison

The maximum IMRX drawdown since its inception was -96.86%, which is greater than ESLT's maximum drawdown of -53.79%. Use the drawdown chart below to compare losses from any high point for IMRX and ESLT.

Drawdown Indicators

	IMRX	ESLT	Difference
Max Drawdown Largest peak-to-trough decline	-96.86%	-53.79%	-43.07%
Max Drawdown (1Y) Largest decline over 1 year	-57.67%	-25.98%	-31.69%
Max Drawdown (3Y) Largest decline over 3 years	-90.98%	-25.98%	-65.00%
Max Drawdown (5Y) Largest decline over 5 years	—	-32.89%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-32.89%	—
Current Drawdown Current decline from peak	-87.24%	-15.71%	-71.53%
Average Drawdown Average peak-to-trough decline	-77.61%	-13.91%	-63.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.56%	9.36%	+25.20%

Volatility

IMRX vs. ESLT - Volatility Comparison

Immuneering Corporation (IMRX) has a higher volatility of 33.75% compared to Elbit Systems Ltd (ESLT) at 19.89%. This indicates that IMRX's price experiences larger fluctuations and is considered to be riskier than ESLT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IMRX	ESLT	Difference
Volatility (1M) Calculated over the trailing 1-month period	33.75%	19.89%	+13.86%
Volatility (6M) Calculated over the trailing 6-month period	79.00%	35.93%	+43.07%
Volatility (1Y) Calculated over the trailing 1-year period	124.22%	44.11%	+80.11%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	114.45%	33.66%	+80.79%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.45%	29.42%	+85.03%

Dividends

IMRX vs. ESLT - Dividend Comparison

IMRX has not paid dividends to shareholders, while ESLT's dividend yield for the trailing twelve months is around 0.36%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ESLT Elbit Systems Ltd	0.36%	0.47%	0.77%	0.94%	1.22%	1.03%	1.28%	1.14%	1.54%	1.32%	1.57%	1.63%
IMRX Immuneering Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both IMRX and ESLT in my portfolio?

IMRX and ESLT have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IMRX or ESLT?

IMRX has higher volatility (33.75%) compared to ESLT (19.89%). In terms of maximum drawdown, IMRX dropped -96.86% vs ESLT's -53.79%.

Which has better risk-adjusted returns?

ESLT currently has the higher Sharpe Ratio (2.26 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.